Table 2. Pancreatic cancer incidence in China, 2011.
Areas | Sex | Case No. | Crude rate (1/105) | Ratio (%) | ASIRC (1/105) | ASIRW (1/105) | Cumulative rate 0-74 (%) | TASR 35-64 (1/105) |
---|---|---|---|---|---|---|---|---|
All | Both sexes | 80,344 | 5.96 | 2.38 | 4.27 | 4.23 | 0.5 | 5.68 |
Male | 45,385 | 6.57 | 2.37 | 4.99 | 4.95 | 0.58 | 6.87 | |
Female | 34,959 | 5.32 | 2.4 | 3.58 | 3.55 | 0.42 | 4.45 | |
Urban | Both sexes | 48,568 | 7.03 | 2.69 | 4.94 | 4.9 | 0.57 | 6.14 |
Male | 27,339 | 7.75 | 2.75 | 5.77 | 5.73 | 0.68 | 7.51 | |
Female | 21,229 | 6.28 | 2.61 | 4.13 | 4.09 | 0.47 | 4.73 | |
Rural | Both sexes | 31,776 | 4.84 | 2.03 | 3.56 | 3.52 | 0.42 | 5.16 |
Male | 18,046 | 5.34 | 1.95 | 4.15 | 4.1 | 0.48 | 6.17 | |
Female | 13,730 | 4.31 | 2.14 | 2.99 | 2.96 | 0.35 | 4.12 |
ASIRC, age-standardized incidence rate (using China standard population 2000); ASIRW, age-standardized incidence rate (using World standard population); TASR, truncated age-standardized rate (using World standard population).